Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
FDA
FDA Issues Guidance Documents to Streamline Premarket Review and Approval…
The United States Food and Drug Administration (FDA) recently issued two guidances as part of its Drug Competition Action Plan…
Vanda Lawsuit Against United States for Uncompensated Taking Allowed to…
The United States Court of Federal Claims in Washington, D.C. recently denied the United States’ motion to dismiss Vanda…
Former Medical Device Manufacturing Employee Sentenced to Prison for…
A former employee of a medical device manufacturing company was recently sentenced to 12 months in prison and one year of…
FDA Issues First Untitled Letter of 2024
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently issued the first…
FDA Releases Finalized Guidance on Use of Real-World Data in New Drug and…
Recently, the United States Food and Drug Administration (FDA) finalized two guidance documents that outline how sponsors can use…
New Report Outlines a Roadmap for Restoring Public Trust in the FDA
The Hastings Center recently released a report with a roadmap on how the United States Food and Drug Administration (FDA) can…
FDA Announces Small Entity Compliance Guide on DTC Radio and Television…
On December 27, 2023, the United States Food and Drug Administration (FDA) announced a new small entity compliance guide (SECG),…
Comments Praise and Call for Clarification on FDA DAP Draft Guidance
The United States Food and Drug Administration (FDA) received more than 130 comments on its draft guidance on clinical diversity,…
FDA Releases Final Rule for Direct-to-Consumer Prescription Drug…
Recently, the United States Food and Drug Administration (FDA) released the final rule for Direct-to-Consumer Prescription Drug…
FDA Extends Comment Period on SIUU Draft Guidance
The United States Food and Drug Administration (FDA) has extended the comment period for comments on the revised draft guidance…